SABCS 2024 Insights: Impact of Ribociclib Dose Reduction on Efficacy in HR+/HER2- eBC - Insights From the NATALEE Trial | VuMedi

Find latest Breast Cancer videos · 1000+ videos

SABCS 2024 Insights: Impact of Ribociclib Dose Reduction on Efficacy in HR+/HER2- eBC - Insights From the NATALEE Trial

By 2024 SABCS Annual Meeting Insights Hub FEATURING Erika Hamilton

By 2024 SABCS Annual Meeting Insights Hub FEATURING Erika Hamilton

535 views

January 7, 2025

Comments 1

Login to view comments. Click here to Login